Por favor, use este identificador para citar o enlazar este ítem:https://uvadoc.uva.es/handle/10324/59905
Título
Kirkiin: A new toxic type 2 ribosome-Inactivating protein from the caudex of Adenia kirkii
Autor
Año del Documento
2021
Editorial
MDPI
Descripción
Producción Científica
Documento Fuente
Toxins, 2021, Vol. 13, Nº. 2, 81
Resumen
Ribosome-inactivating proteins (RIPs) are plant toxins that irreversibly damage ribosomes and other substrates, thus causing cell death. RIPs are classified in type 1 RIPs, single-chain enzymatic proteins, and type 2 RIPs, consisting of active A chains, similar to type 1 RIPs, linked to lectin B chains, which enable the rapid internalization of the toxin into the cell. For this reason, many type 2 RIPs are very cytotoxic, ricin, volkensin and stenodactylin being the most toxic ones. From the caudex of Adenia kirkii (Mast.) Engl., a new type 2 RIP, named kirkiin, was purified by affinity chromatography on acid-treated Sepharose CL-6B and gel filtration. The lectin, with molecular weight of about 58 kDa, agglutinated erythrocytes and inhibited protein synthesis in a cell-free system at very low concentrations. Moreover, kirkiin was able to depurinate mammalian and yeast ribosomes, but it showed little or no activity on other nucleotide substrates. In neuroblastoma cells, kirkiin inhibited protein synthesis and induced apoptosis at doses in the pM range. The biological characteristics of kirkiin make this protein a potential candidate for several experimental pharmacological applications both alone for local treatments and as component of immunoconjugates for systemic targeting in neurodegenerative studies and cancer therapy.
Materias (normalizadas)
Plant toxins
Toxinas
Proteins - Synthesis
Proteínas
Ribosomes - Structure
Apoptosis
Lectins
Neuroblastoma
Pharmacology/Toxicology
Materias Unesco
3209 Farmacología
3214 Toxicología
2302 Bioquímica
Palabras Clave
Ribosome-inactivating protein
ISSN
2072-6651
Revisión por pares
SI
Patrocinador
Universidad de Bolonia y Pallotti Legacies for Cancer Research; Fundación CARISBO - (Project 2019.0539)
Junta de Castilla y León - (Grant VA033G19)
Junta de Castilla y León - (Grant VA033G19)
Version del Editor
Propietario de los Derechos
© 2021 The authors
Idioma
eng
Tipo de versión
info:eu-repo/semantics/publishedVersion
Derechos
openAccess
Aparece en las colecciones
Ficheros en el ítem
La licencia del ítem se describe como Atribución 4.0 Internacional